<p>THURSDAY, Apr 19 (<span>HealthDay News</span>) — It’s not transparent whether
patients with <span>type 2 diabetes</span> advantage any long-term advantage from holding the
blood sugar-lowering drug <span>metformin</span> and <span>insulin</span> together rather than
insulin alone.</p>
<p>That’s a end of <span>Danish researchers</span> who reviewed information from 23<span>clinical trials</span> involving some-more than 2,200 patients over a age of 18.</p>
<p>Reporting online Apr 19 in a BMJ, they found that taking
metformin and insulin leads to improved <span>blood sugarine control</span>, reduction weight
gain and reduction need for insulin.</p>
<p>However, a researchers also remarkable that a clinical trials provided
little information about long-term studious outcomes, such as a total
numbers of deaths and deaths from cardiovascular disease.</p>
<...
0 comments
Post a Comment